These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 36997106)

  • 1. Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer.
    Muilenburg KM; Isder CC; Radhakrishnan P; Batra SK; Ly QP; Carlson MA; Bouvet M; Hollingsworth MA; Mohs AM
    Cancer Lett; 2023 May; 561():216150. PubMed ID: 36997106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic mouse models.
    Hiroshima Y; Maawy A; Zhang Y; Sato S; Murakami T; Yamamoto M; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    PLoS One; 2014; 9(6):e99977. PubMed ID: 24924955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expressing Pancreatic Cancer.
    Olson MT; Aguilar EN; Brooks CL; Isder CC; Muilenburg KM; Talmon GA; Ly QP; Carlson MA; Hollingsworth MA; Mohs AM
    Mol Pharm; 2022 Oct; 19(10):3586-3599. PubMed ID: 35640060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
    Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
    Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Innovation for Treating Orthotopic Pancreatic Cancer by Preoperative Screening and Imaging-Guided Surgery.
    Han Z; Shang W; Liang X; Yan H; Hu M; Peng L; Jiang H; Fang C; Wang K; Tian J
    Mol Imaging Biol; 2019 Feb; 21(1):67-77. PubMed ID: 29858735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a MUC16-Targeted Near-Infrared Fluorescent Antibody Conjugate for Intraoperative Imaging of Pancreatic Cancer.
    Olson MT; Wojtynek NE; Talmon GA; Caffrey TC; Radhakrishnan P; Ly QP; Hollingsworth MA; Mohs AM
    Mol Cancer Ther; 2020 Aug; 19(8):1670-1681. PubMed ID: 32404409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratiometric activatable cell-penetrating peptides label pancreatic cancer, enabling fluorescence-guided surgery, which reduces metastases and recurrence in orthotopic mouse models.
    Metildi CA; Felsen CN; Savariar EN; Nguyen QT; Kaushal S; Hoffman RM; Tsien RY; Bouvet M
    Ann Surg Oncol; 2015; 22(6):2082-7. PubMed ID: 25319581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving precision surgery: A review of current intraoperative nerve tissue fluorescence imaging.
    Wang LG; Gibbs SL
    Curr Opin Chem Biol; 2023 Oct; 76():102361. PubMed ID: 37454623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice.
    Hiroshima Y; Maawy A; Sato S; Murakami T; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Surg Res; 2014 Apr; 187(2):510-7. PubMed ID: 24373959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of fluorescence guided surgery for pancreatic cancer: from bench to clinic.
    Lwin TM; Hoffman RM; Bouvet M
    Expert Rev Anticancer Ther; 2018 Jul; 18(7):651-662. PubMed ID: 29768067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse models.
    Metildi CA; Kaushal S; Hardamon CR; Snyder CS; Pu M; Messer KS; Talamini MA; Hoffman RM; Bouvet M
    J Am Coll Surg; 2012 Jul; 215(1):126-35; discussion 135-6. PubMed ID: 22632917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery.
    Gutowski M; Framery B; Boonstra MC; Garambois V; Quenet F; Dumas K; Scherninski F; Cailler F; Vahrmeijer AL; Pèlegrin A
    Surg Oncol; 2017 Jun; 26(2):153-162. PubMed ID: 28577721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A translational blueprint for developing intraoperative imaging agents via radiopharmaceutical-guided drug design.
    Sullivan TE; Hernandez Vargas S; Ghosh SC; AghaAmiri S; Ikoma N; Azhdarinia A
    Curr Opin Chem Biol; 2023 Oct; 76():102376. PubMed ID: 37572489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical Surgical Navigation for Precision in Tumor Resections.
    Harmsen S; Teraphongphom N; Tweedle MF; Basilion JP; Rosenthal EL
    Mol Imaging Biol; 2017 Jun; 19(3):357-362. PubMed ID: 28271367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
    Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
    Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
    [No Abstract]   [Full Text] [Related]  

  • 16. Design of Protease Activated Optical Contrast Agents That Exploit a Latent Lysosomotropic Effect for Use in Fluorescence-Guided Surgery.
    Ofori LO; Withana NP; Prestwood TR; Verdoes M; Brady JJ; Winslow MM; Sorger J; Bogyo M
    ACS Chem Biol; 2015 Sep; 10(9):1977-88. PubMed ID: 26039341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of optical imaging agents in a fluorescence-guided surgical model of head and neck cancer.
    Prince AC; Moore LS; Tipirneni KE; Ramesh T; Limdi MA; Bevans SL; Walsh EM; Greene B; Rosenthal EL; Warram JM
    Surg Oncol; 2018 Jun; 27(2):225-230. PubMed ID: 29937175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic cancer.
    Qi B; Crawford AJ; Wojtynek NE; Holmes MB; Souchek JJ; Almeida-Porada G; Ly QP; Cohen SM; Hollingsworth MA; Mohs AM
    Nanomedicine; 2018 Apr; 14(3):769-780. PubMed ID: 29325740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
    Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Targeting of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery.
    Hernandez Vargas S; Kossatz S; Voss J; Ghosh SC; Tran Cao HS; Simien J; Reiner T; Dhingra S; Fisher WE; Azhdarinia A
    Clin Cancer Res; 2019 Jul; 25(14):4332-4342. PubMed ID: 31015345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.